annual retained earnings:
$20.06B+$4.52B(+29.11%)Summary
- As of today (September 12, 2025), NVO annual retained earnings is $20.06 billion, with the most recent change of +$4.52 billion (+29.11%) on December 31, 2024.
- During the last 3 years, NVO annual retained earnings has risen by +$9.05 billion (+82.19%).
- NVO annual retained earnings is now at all-time high.
Performance
NVO Retained earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly retained earnings:
$25.87B+$5.99B(+30.14%)Summary
- As of today (September 12, 2025), NVO quarterly retained earnings is $25.87 billion, with the most recent change of +$5.99 billion (+30.14%) on June 1, 2025.
- Over the past year, NVO quarterly retained earnings has increased by +$9.76 billion (+60.53%).
- NVO quarterly retained earnings is now at all-time high.
Performance
NVO quarterly retained earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Retained earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
NVO Retained earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +29.1% | +60.5% |
| 3 y3 years | +82.2% | +151.6% |
| 5 y5 years | +130.9% | +186.1% |
NVO Retained earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +82.2% | at high | +166.6% |
| 5 y | 5-year | at high | +130.9% | at high | +186.1% |
| alltime | all time | at high | +9505.8% | at high | >+9999.0% |
NVO Retained earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $25.87B(+30.1%) |
| Mar 2025 | - | $19.88B(-0.9%) |
| Dec 2024 | $20.06B(+29.1%) | $20.06B(+10.1%) |
| Sep 2024 | - | $18.22B(+13.0%) |
| Jun 2024 | - | $16.12B(+12.4%) |
| Mar 2024 | - | $14.34B(-7.7%) |
| Dec 2023 | $15.54B(+34.3%) | $15.54B(+19.3%) |
| Sep 2023 | - | $13.02B(+0.9%) |
| Jun 2023 | - | $12.91B(+14.9%) |
| Mar 2023 | - | $11.24B(-2.8%) |
| Dec 2022 | $11.57B(+5.1%) | $11.57B(+19.1%) |
| Sep 2022 | - | $9.71B(-5.6%) |
| Jun 2022 | - | $10.29B(+3.2%) |
| Mar 2022 | - | $9.96B(-9.5%) |
| Dec 2021 | $11.01B(+5.0%) | $11.01B(+4.0%) |
| Sep 2021 | - | $10.58B(-1.2%) |
| Jun 2021 | - | $10.71B(+12.4%) |
| Mar 2021 | - | $9.53B(-9.1%) |
| Dec 2020 | $10.48B(+20.7%) | $10.48B(+11.2%) |
| Sep 2020 | - | $9.43B(+4.3%) |
| Jun 2020 | - | $9.04B(+12.1%) |
| Mar 2020 | - | $8.07B(-7.1%) |
| Dec 2019 | $8.69B(+6.2%) | $8.69B(+10.7%) |
| Sep 2019 | - | $7.84B(-4.0%) |
| Jun 2019 | - | $8.17B(+11.8%) |
| Mar 2019 | - | $7.31B(-10.7%) |
| Dec 2018 | $8.18B(+3.6%) | $8.18B(+7.2%) |
| Sep 2018 | - | $7.63B(-3.9%) |
| Jun 2018 | - | $7.94B(+10.2%) |
| Mar 2018 | - | $7.20B(-8.8%) |
| Dec 2017 | $7.90B(+20.8%) | $7.90B(+9.9%) |
| Sep 2017 | - | $7.19B(-0.3%) |
| Jun 2017 | - | $7.21B(+23.1%) |
| Mar 2017 | - | $5.86B(-10.4%) |
| Dec 2016 | $6.54B(-4.0%) | $6.54B(+5.6%) |
| Sep 2016 | - | $6.20B(-2.4%) |
| Jun 2016 | - | $6.35B(+15.1%) |
| Mar 2016 | - | $5.52B(-19.0%) |
| Dec 2015 | $6.81B(+1.6%) | $6.81B(+6.4%) |
| Sep 2015 | - | $6.40B(+8.9%) |
| Jun 2015 | - | $5.88B(+17.5%) |
| Mar 2015 | - | $5.00B(-25.4%) |
| Dec 2014 | $6.71B(-11.7%) | $6.71B(+2.0%) |
| Sep 2014 | - | $6.57B(-0.8%) |
| Jun 2014 | - | $6.63B(+11.0%) |
| Mar 2014 | - | $5.97B(-21.4%) |
| Dec 2013 | $7.60B | $7.60B(+10.7%) |
| Sep 2013 | - | $6.86B(+15.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2013 | - | $5.95B(+6.2%) |
| Mar 2013 | - | $5.60B(-18.8%) |
| Dec 2012 | $6.89B(+6.3%) | $6.89B(+15.4%) |
| Sep 2012 | - | $5.97B(+13.4%) |
| Jun 2012 | - | $5.26B(-6.0%) |
| Mar 2012 | - | $5.60B(-13.6%) |
| Dec 2011 | $6.48B(-0.3%) | $6.48B(+3.1%) |
| Sep 2011 | - | $6.28B(-8.8%) |
| Jun 2011 | - | $6.89B(+8.8%) |
| Mar 2011 | - | $6.33B(-2.6%) |
| Dec 2010 | $6.50B(-2.1%) | $6.50B(+6.3%) |
| Sep 2010 | - | $6.12B(+9.8%) |
| Jun 2010 | - | $5.57B(-5.0%) |
| Mar 2010 | - | $5.87B(-11.6%) |
| Dec 2009 | $6.64B(+6.3%) | $6.64B(+0.8%) |
| Sep 2009 | - | $6.59B(+4.9%) |
| Jun 2009 | - | $6.29B(+11.3%) |
| Mar 2009 | - | $5.65B(-9.5%) |
| Dec 2008 | $6.24B(+3.9%) | $6.24B(+3.8%) |
| Sep 2008 | - | $6.01B(-8.6%) |
| Jun 2008 | - | $6.58B(+5.0%) |
| Mar 2008 | - | $6.27B(+4.3%) |
| Dec 2007 | $6.01B(+18.0%) | $6.01B(-0.7%) |
| Sep 2007 | - | $6.06B(+3.9%) |
| Jun 2007 | - | $5.83B(+14.7%) |
| Mar 2007 | - | $5.08B(-0.3%) |
| Dec 2006 | $5.10B(+19.5%) | $5.10B(+19.5%) |
| Dec 2005 | $4.26B(+2.9%) | $4.26B(+2.9%) |
| Dec 2004 | $4.14B(+15.9%) | $4.14B(+15.9%) |
| Dec 2003 | $3.57B(+32.8%) | $3.57B(+32.8%) |
| Dec 2002 | $2.69B(+36.5%) | $2.69B(+36.5%) |
| Dec 2001 | $1.97B(-10.8%) | $1.97B(-10.8%) |
| Dec 2000 | $2.21B(-11.0%) | $2.21B(+40.2%) |
| Dec 1999 | $2.48B(-4.9%) | $1.58B(-30.3%) |
| Dec 1998 | $2.61B(+22.9%) | $2.26B(+5.8%) |
| Dec 1997 | $2.12B(-0.4%) | $2.14B(+0.9%) |
| Dec 1996 | $2.13B(+7.3%) | $2.12B(+6.9%) |
| Dec 1995 | $1.99B(+24.3%) | $1.98B(+24.0%) |
| Dec 1994 | $1.60B(+27.5%) | $1.60B(+26.8%) |
| Dec 1993 | $1.26B(+9.6%) | $1.26B(+10.2%) |
| Dec 1992 | $1.15B(+10.5%) | $1.15B(+10.5%) |
| Dec 1991 | $1.04B(+23.8%) | $1.04B(+23.9%) |
| Dec 1990 | $836.90M(+35.9%) | $836.53M(+36.4%) |
| Dec 1989 | $615.83M(+22.5%) | $613.38M(+22.0%) |
| Dec 1988 | $502.64M(-1.5%) | $502.64M(-1.5%) |
| Dec 1987 | $510.48M(+30.1%) | $510.48M(+30.1%) |
| Dec 1986 | $392.49M(+22.7%) | $392.49M(+22.7%) |
| Dec 1985 | $319.90M(+53.2%) | $319.90M(+53.2%) |
| Dec 1984 | $208.81M | $208.81M |
FAQ
- What is Novo Nordisk A/S annual retained earnings?
- What is the all time high annual retained earnings for Novo Nordisk A/S?
- What is Novo Nordisk A/S annual retained earnings year-on-year change?
- What is Novo Nordisk A/S quarterly retained earnings?
- What is the all time high quarterly retained earnings for Novo Nordisk A/S?
- What is Novo Nordisk A/S quarterly retained earnings year-on-year change?
What is Novo Nordisk A/S annual retained earnings?
The current annual retained earnings of NVO is $20.06B
What is the all time high annual retained earnings for Novo Nordisk A/S?
Novo Nordisk A/S all-time high annual retained earnings is $20.06B
What is Novo Nordisk A/S annual retained earnings year-on-year change?
Over the past year, NVO annual retained earnings has changed by +$4.52B (+29.11%)
What is Novo Nordisk A/S quarterly retained earnings?
The current quarterly retained earnings of NVO is $25.87B
What is the all time high quarterly retained earnings for Novo Nordisk A/S?
Novo Nordisk A/S all-time high quarterly retained earnings is $25.87B
What is Novo Nordisk A/S quarterly retained earnings year-on-year change?
Over the past year, NVO quarterly retained earnings has changed by +$9.76B (+60.53%)